{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-007565","form_type":"8-K","ticker":"SRXH","cik":"0001471727","company_name":"SRx Health Solutions, Inc.","filed_at":"2026-02-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.141090+00:00","generated_at":"2026-05-16T01:26:33.272937+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"SRx Health Solutions receives NYSE American warning letter over 7.5M share issuance without approval","bullets":["NYSE American issued public warning letter on Feb 18, 2026 citing violations of Sections 301 and 713.","Company failed to file listing application and obtain shareholder approval for issuance of approx. 7.5 million shares upon conversion of Series A Preferred Stock.","Company had obtained stockholder approval by written consent on Oct 8, 2025, but NYSE deemed it deficient under internal guidance.","All preferred shares have been converted or redeemed as of report date; no preferred shares outstanding.","Company filed Form 8-K and press release on Feb 20, 2026 disclosing the warning letter."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-007565","json":"https://secwatch.observer/filing/0001493152-26-007565.json","markdown":"https://secwatch.observer/filing/0001493152-26-007565.md","text":"https://secwatch.observer/filing/0001493152-26-007565.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1471727/000149315226007565/0001493152-26-007565-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1471727/000149315226007565/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-16T01:26:33.272937+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d96cc47b5cbc643a150f50a972270184160cf949","claim":"SRx Health Solutions, Inc. received a nyse_american noncompliance notice notice regarding other (rules 301, 713).","evidence_excerpt":"February 18, 2026, SRx Health Solutions, Inc. (the “Company”) received a public warning letter (the “Letter”) from the NYSE Regulation Staff of the New York Stock Exchange (the “Exchange”) notifying the Company that it failed to comply with Sections 301 and 713 of the NYSE American LLC Company Guide (the “Company Guide”). The Letter relates to the issuance of approximately 7.5 million shares (the “Subject Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), between December 31, 2025 and January 23, 2026, upon conversion of certain shares of the Company’s Ser","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1471727/000149315226007565/0001493152-26-007565-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nyse american"},{"label":"Notice","value":"noncompliance notice"},{"label":"Rules","value":"301, 713"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}